Moleculin Biotech Inc (MBRX) — Financial Flexibility Index
Moleculin Biotech Inc (MBRX) has a Financial Flexibility Index of -0.75x as of December 2025. Free cash flow of $-5.37 Million (operating CF $-5.37 Million minus capex $0.00) represents -1% of total liabilities ($7.12 Million). Also explore MBRX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Moleculin Biotech Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Moleculin Biotech Inc across 11 annual periods. Check Moleculin Biotech Inc (MBRX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Moleculin Biotech Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Moleculin Biotech Inc. For the full company profile including market capitalisation, see Moleculin Biotech Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.19x | $-22.73 Million | $-22.73 Million | $7.12 Million | ▼ -46.6% |
| 2024 | -2.18x | $-23.85 Million | $-23.86 Million | $10.95 Million | ▼ -10.4% |
| 2023 | -1.97x | $-23.98 Million | $-24.10 Million | $12.14 Million | ▲ +62.5% |
| 2022 | -5.27x | $-27.57 Million | $-27.64 Million | $5.23 Million | ▼ -41.9% |
| 2021 | -3.71x | $-18.93 Million | $-18.95 Million | $5.10 Million | ▼ -140.7% |
| 2020 | -1.54x | $-17.39 Million | $-17.77 Million | $11.27 Million | ▲ +13.0% |
| 2019 | -1.77x | $-17.15 Million | $-17.20 Million | $9.66 Million | ▲ +20.0% |
| 2018 | -2.22x | $-11.79 Million | $-12.20 Million | $5.31 Million | ▲ +28.1% |
| 2017 | -3.08x | $-7.30 Million | $-7.32 Million | $2.37 Million | ▼ -18.1% |
| 2016 | -2.61x | $-3.74 Million | $-3.76 Million | $1.43 Million | ▼ -401.7% |
| 2015 | -0.52x | $-402.51K | $-423.51K | $772.79K | — |